Ajanta Pharma has partnered with Biocon for exclusive or semi-exclusive rights in 26 countries across Asia and Africa
More plans are now recognizing and covering FDA-approved weight loss medications like Wegovy and Zepbound, making achieving your weight loss goals more feasible than ever
Endocr J (2016) 63(6):58996
Obesity For weight loss, healthcare professionals may prescribe GLP-1 agonists for people with an initial BMI of 30 or higher or people who have a BMI of 27 or higher and at least one weight-related health condition, such as: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea polycystic ovary syndrome Typically, healthcare professionals only prescribe these medications after someone has tried other weight loss methods, such as diet and exercise, without success
PMCID: PMC12155186
Side effects and safety considerations The most common side effects of GLP-1 medications are gastrointestinal and include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort